Literature DB >> 6695475

Stage D1 adenocarcinoma of prostate.

R E Donohue, J H Mani, J A Whitesel, S Mohr, D Scanavino, R R Augspurger, R J Biber, H E Fauver, J N Wettlaufer, R R Pfister.   

Abstract

The natural history of Stage D1 adenocarcinoma of the prostate remains unclear. In a series of 50 patients with positive pelvic lymph nodes at the time of staging lymphadenectomy, metastatic disease developed in 43 per cent of the patients treated for cure within the period of time of follow-up. Several series from the literature confirm those findings. Positive pelvic lymph nodes most probably represent systemic disease, and the patients are incurable by current surgical and radiotherapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6695475     DOI: 10.1016/0090-4295(84)90002-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Prostate cancer: to screen or not to screen?

Authors:  F H Schröder
Journal:  BMJ       Date:  1993-02-13

Review 2.  Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.

Authors:  J L Mohler; B T Williams; I M Thompson; M E Marshall
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.